One-year follow-up data suggest that a novel transcatheter tricuspid valve replacement (TTVR ... 38.3- and 6.4-mL drops in right atrial systolic volume and mid right ventricular end-systolic volume, ...

Abbott Laboratories, Inc. ABT recently announced the first patient procedures with its investigational transcatheter ... saving HeartMate 3 left ventricular assist device (LVAD or heart pump ...

The HeartMate II is currently the only continuous-flow left-ventricular assist device (LVAD) approved by the FDA for both bridge-to-transplantation and destination therapy. Because of its ...

Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload ...

This latest certification specifically acknowledges the hospital’s expertise in Transcatheter Aortic ... and life-saving Left Ventricular Assist Device (LVAD) procedures. In 2023, Lenmed ...

The global transcatheter mitral valve market is on a strong growth trajectory, with projections estimating a market valuation of USD 1.6 billion by the end of 2024 and an impressive compound annual ...